Кредиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 24.71M 80.91M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Gilead Sciences USD 715M 93M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 31M 9.57M 2025-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xencor USD 10.83M 1.75M 2025-12